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doi:10.1016/j.asjsur.2011.11.001Summary We report a 26-year-old man with 6 years, history of duodenal gastrointestinal
stromal tumor (GIST) with liver, peritoneum and lung metastases. He presented with left
eye ptosis, diplopia, left facial numbness and a left temporal fossa mass that was confirmed
to be GISTwith left skull and left orbit metastases. Craniectomy with cranioplasty, tumor exci-
sion and decompression were performed. There was an improvement of his visual symptoms
and facial numbness. To our knowledge, this is one of the few reports of surgical management
of GIST, metastasized to skull and orbit, with good symptomatic relief.
Copyright ª 2011, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Gastrointestinal stromal tumor (GIST) is a rare mesen-
chymal tumor of the gastrointestinal tract. Like other
gastrointestinal tract tumors, abdominal viscera are
common sites of metastasis. We present our patient with
rare GIST metastasis to the skull and orbit managed by
surgery.eurosurgery, Department of
ine, The University of Hong
om (L.-F. Li).
n Surgical Association. Published2. Case presentation
Our patient was a 26-year-old man who presented in 2004
for passing tarry stool and who was anemic. Esophagogas-
troduodenoscopy found two polypoid lesions in the
duodenum. Biopsy showed that it consisted of small round
cells with eosinophilic cytoplasm, no atypia or mitosis.
Immunohistochemistry were positive for CD117, CD34 and
smooth muscle actin. It was compatible with GIST. Positron
emission tomography (PET) and computed tomography (CT)
scans showed a duodenal tumor of size 5.6 3.4 4 cm3
with liver metastases. Imatinib was started and his clinical
condition remained static but he required frequent blood
transfusion.by Elsevier Taiwan LLC. All rights reserved.
Figure 2 Intraoperative photo after the temporalis muscle
was lifted up. A reddish soft tumor had eroded through the
skull bone and infiltrated the temporalis muscle.
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by the tumor. Gastrojejunostomy was performed to bypass
the obstruction. Imatinib was replaced by sunitinib and two
percutaneous radiofrequency ablations for the liver metas-
tases were performed. However, the disease continued to
progress with lung metastases. Sunitinib was changed to
nilotinib.
He then complained of left facial numbness and diplopia
in February 2010. There was facial asymmetry and his left
eye protruded. There was a bulge over the left temporal
fossa that was firm and nontender. The overlying skin
looked normal. He had diplopia in all gaze but no oph-
thalmoplegia. There was numbness over the maxillary
branch of the left trigeminal nerve. The visual acuities of
the right and left eyes were 20/20 and 20/25, respectively,
but he complained that the image from the left eye was
significantly dimmer. Visual fields of both eyes were full.
Magnetic resonance imaging (MRI) showed a 5 cm contrast
enhanced lesion over the left temporal region with exten-
sion into the left orbit displacing the globe. CT scan showed
that the left orbital roof and part of the left temporal
bone were eroded by the tumor (Fig. 1). There was also
midline shift.
Craniotomy was performed in March 2010. The skin was
spared but the temporalis muscle was invaded by the
tumor and was partially removed. The tumor had eroded
the pterion (Fig. 2). After craniectomy, the tumor was
found to have eroded the lateral and superior orbital walls
and had compressed onto the globe. Medially, it extended
along the greater wing of the sphenoid and had invaded the
anterior clinoid process causing optic nerve compression.
Inferiorly, it extended to the cavernous sinus and middle
cranial fossa. The periorbita and dura were intact. The
anterior clinoid process was removed and the optic canal
was opened for optic nerve decompression. Because of the
extensive skull base involvement, only a partial removal
was achieved. The skull defect was repaired with meth-
acrylate (Fig. 3).
After the operation, proptosis of the left eye was
resolved. There was a markedly subjective improvement ofFigure 1 (Left) Preoperative plain computed tomography of the
displaced and (Right) involved the left temporal region.diplopia. Vision of the left eye was improved with brighter
image. The numbness over the left face had also
decreased. The patient was discharged 5 days after the
operation. Histology exams showed that the nuclei of the
tumor cells were large, hyperchromatic and pleomorphic
with coarse chromatin. Mitoses were 23 per 10 high-power
fields. Immunohistochemistry was positive for CD117
and CD34 that was compatible with GIST (Fig. 4). He
received external beam irradiation and continued nilotinib
afterwards.
3. Discussion
The head is a rare site for GIST metastases. There have
been a few reports on cerebral metastases,1e3 one with
clival metastases treated by tyrosine kinase inhibitors
(TKI),4 one had skull vault metastasis with excisional
biopsy5 and one had metastasis to the orbit and optic canal
causing optic nerve compression.6 In the last report,brain showed tumor extending into the orbit with the eyeball
Figure 3 (Left) Postoperative plain computed tomography of the brain showing good decompression of the orbit and (Right) the
brain with cranioplasty performed.
Figure 4 (Left) Hematoxylin and eosin staining of the tumor and (Right) positive immunohistochemistry staining for CD117
(original magnifications 40).
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taken. External beam irradiation was used, but only
achieved pain relief without vision improvement. In
comparison, our patient suffered from more extensive
involvement causing proptosis. Our surgical decompression
provided quick vision improvement, relief from the cere-
bral compression and good cosmesis. Intact periorbita and
dura enabled a relatively safe procedure. As only a partial
excision was achieved, external beam irradiation was
needed for better disease control. Treatment failure with
different TKIs poses difficulties with future planning. It is
believed that the disease will recur soon and the value of
further surgical resection is doubtful without adjuvant
therapy.
Small intestinal GISTs have been shown to be more
aggressive than its gastric counterpart.7 Both the size of the
primary GIST and mitotic activity are related to biological
activities. In our patient, there was no mitotic figure in the
duodenum biopsy but there were high mitotic activities in
the orbit metastasis. It is uncertain if: 1) the mitotic figure
had been properly evaluated from the small duodenal
biopsy; 2) this is the usual progress with an increase inmitotic figure; 3) the use of TKIs resulted in clonal selec-
tion; or 4) the metastasis represents a clone with high
mitotic figure and aggressive behavior while the duodenum
tumor remained unchanged. In the last case, further surgery
may be warranted as symptomatic control, provided that
other systemic tumors remain static.
In summary, this is one of the few reported cases of GIST
that metastasized to the skull and orbit, which was
managed surgically with good symptomatic relief.References
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